Literature DB >> 18375104

Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem.

Anna Farra1, Sohidul Islam, Annelie Strålfors, Mikael Sörberg, Bengt Wretlind.   

Abstract

The main mechanism of imipenem resistance in Pseudomonas aeruginosa is via downregulation of the gene for OprD porin. In a previous study, it was shown that the level of resistance did not parallel with the degree of downregulation of the porin gene, thus arguing for the existence of other resistance mechanisms. Penicillin-binding protein (PBP) 2 and PBP3 are involved in carbapenem resistance in Escherichia coli. The genes for PBPs were sequenced in three imipenem-resistant clinical strains and these strains were conjugated with two susceptible P. aeruginosa PA0 strains, selecting for auxotrophic markers. In all the clinical and resistant isolates there was no obvious elevation of AmpC cephalosporinase. The active sites of PBP1b (ponB), PBP2 (pbpA), PBP3 (pbpB) and PBP6 (dacC) had no mutations in any of the examined strains. Production of oprD mRNA was significantly lower in clinical strains and transconjugants after selection for the proB marker (PA4565 at 5113kb). The clinical strains had alterations in OprD that were not found in transconjugants. Our findings suggest that PBPs do not play a role in imipenem resistance in the clinical strains examined here, but that a regulatory gene for oprD contributing to carbapenem resistance is located close to the proB gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375104     DOI: 10.1016/j.ijantimicag.2007.12.016

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  19 in total

1.  Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.

Authors:  Phillip J Bergen; Jürgen B Bulitta; Carl M J Kirkpatrick; Kate E Rogers; Megan J McGregor; Steven C Wallis; David L Paterson; Roger L Nation; Jeffrey Lipman; Jason A Roberts; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 2.  Emergence of antibiotic-resistant extremophiles (AREs).

Authors:  Prashant Gabani; Dhan Prakash; Om V Singh
Journal:  Extremophiles       Date:  2012-08-21       Impact factor: 2.395

3.  Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.

Authors:  Bartolomé Moyá; Alejandro Beceiro; Gabriel Cabot; Carlos Juan; Laura Zamorano; Sebastián Alberti; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

4.  Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.

Authors:  Craig J McPherson; Lisa M Aschenbrenner; Brian M Lacey; Kelly C Fahnoe; Margaret M Lemmon; Steven M Finegan; Baswanth Tadakamalla; John P O'Donnell; John P Mueller; Andrew P Tomaras
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

5.  Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.

Authors:  Alain A Ocampo-Sosa; Gabriel Cabot; Cristina Rodríguez; Elena Roman; Fe Tubau; María D Macia; Bartolomé Moya; Laura Zamorano; Cristina Suárez; Carmen Peña; María A Domínguez; Gabriel Moncalián; Antonio Oliver; Luis Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

6.  PA2800 plays an important role in both antibiotic susceptibility and virulence in Pseudomonas aeruginosa.

Authors:  Lixin Shen; Xiangli Gao; Jinhua Wei; Lin Chen; Xin Zhao; Bo Li; Kangmin Duan
Journal:  Curr Microbiol       Date:  2012-08-10       Impact factor: 2.188

Review 7.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

8.  Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa.

Authors:  Andrew P Tomaras; Jared L Crandon; Craig J McPherson; Mary Anne Banevicius; Steven M Finegan; Rebecca L Irvine; Matthew F Brown; John P O'Donnell; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

9.  Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.

Authors:  G Meletis; N Vavatsi; M Exindari; E Protonotariou; E Sianou; C Haitoglou; D Sofianou; S Pournaras; E Diza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-06       Impact factor: 3.267

10.  Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa.

Authors:  G Meletis; M Exindari; N Vavatsi; D Sofianou; E Diza
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.